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ABSTRACT
Fast field-cycling (FFC) nuclear magnetic resonance relaxometry is a well-established method to
determine the relaxation rates as a function of magnetic field strength. This so-called nuclear mag-
netic relaxation dispersion gives insight into the underlying molecular dynamics of a wide range
of complex systems and has gained interest especially in the characterisation of biological tissues
and diseases. The combination of FFC techniques with magnetic resonance imaging (MRI) offers a
high potential for new types of image contrast more specific to pathological molecular dynamics.
This article reviews the progress in FFC-MRI over the last decade and gives an overview of the hard-
ware systems currently in operation.We discuss limitations and error correction strategies specific to
FFC-MRI such as field stability and homogeneity, signal-to-noise ratio, eddy currents and acquisition
time. We also report potential applications with impact in biology and medicine. Finally, we discuss
the challenges and future applications in transferring the underlyingmolecular dynamics into novel
types of image contrast by exploiting the dispersive properties of biological tissue or MRI contrast
agents.
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Introduction
Magnetic Resonance Imaging (MRI) has emerged as one
of the most versatile imaging modalities in clinical diag-
nosis, providing a wealth of contrast mechanisms. In
this respect, human (clinical) and animal (pre-clinical)
MRI scans typically exploit differences in local proton
(1H) density (mostly tissue water content) and spatially
varying longitudinal (T1) and transverse (T2 and T2*)
relaxation times or equivalently of their inverse, referred
to as the relaxation rates R1 and R2 (and R2*), respec-
tively, measured at the fixed imaging magnetic field B0
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of the scanner. Differences in the underlying relaxation
behaviour at B0, and therefore changes in image con-
trast, can be used to distinguish between healthy and
pathological tissues for many diseases [1]. However, con-
trast mechanisms may change dramatically with the
appliedmagnetic field strength, and these changes can be
exploited to obtain new information for medical diagno-
sis. One way to access field-dependant information is by
using Fast Field-Cycling (FFC) methods.
FFC Nuclear Magnetic Resonance (NMR) relaxom-
etry is an established method to measure the changes
© 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group
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Figure 1. Example of a typical pulse sequence for FFC-NMR. The
top line represents the main magnetic ﬁeld, switching from 0 to
polarisation BP0 and evolution B
E
0 followed by a transition to the
detection ﬁeld BD0 . At the bottom the radiofrequency pulse and
signal acquisition timing. Note that the transitions between the
plateaus are much shorter than the typical T1 values, a necessary
condition for FFC-NMR.
of relaxation times with the field strength B0, referred
to as Nuclear Magnetic Relaxation Dispersion (NMRD)
profiles. The magnetic field strength is typically rapidly
cycled during the FFC-NMR experiment, allowing relax-
ation to occur at a wide range of field strengths but always
returning to the same magnetic field for detection of
NMR signals [2]. As an example Figure 1 shows a FFC-
NMR pulse sequence. B0 varies over time to form three
plateaus: the first one is for polarisation and increases
the amplitude of the signal response, the second plateau
leaves the spin system to evolve at the field of interest with
its corresponding T1 value and the last plateau serves for
detection of the 1H NMR signal.
Repeating this sequence with different evolution times
allows finding T1 at the evolution field, so that repeat-
ing the overall method for different evolution fields pro-
vides a measurement of the dispersion of R1 (an example
of a 1H R1 NMRD profile is shown on Figure 2). As
R1 relaxation mostly depends on characteristic times of
microscopic motions (such as translation and rotation)
and possible energy dissipation throughmatching energy
levels of some molecular structures (such as interactions
with quadrupole nuclei), R1 NMRD profiles give insight
into the molecular dynamics and structural order of a
wide range of complex systems such as organic solids,
metals, polymers, liquid crystals, porous media, exoge-
nous contrasts agents or biological systems [3–6]. While
used for a long time as a tool in the development phases of
MRI contrast agents, over the last decade FFC-NMR has
gained interest in the characterisation of biological tis-
sues and diseases [7–10] by either exploiting the endoge-
nous 1H R1 NMRD profile itself, or its modifications
produced by exogenous contrast agents. These results
demonstrate that FFC methods have a great potential in
Figure 2. 1H R1 NMRD proﬁle of healthy human cartilage
obtained from the Aberdeen FFC-MRI research group [10]. Car-
tilage shows a marked dispersion over several decades of ﬁeld
strength, or equivalently proton Larmor frequency. Quadrupole
peaks can also be observed around 2.5MHz that inform on
water–protein interactions.
medicine if combined with MRI and much efforts are
dedicated to create FFC-MRI scanners [11–15].
Fast field-cycling adds an extra dimension to MRI
by allowing the B0 field to be changed during the pulse
sequence and an optimal magnetic field can be selected
for each of the main phases of an MRI pulse sequence
(polarisation, relaxation and acquisition). This allows the
generation of images displaying the variation of R1 with
respect to the magnetic field in ex vivo and in vivo bio-
logical tissues, non-invasively, with a high potential to
generate new types of image contrast specific to patho-
logical molecular dynamics and thus useful for disease
characterisation and diagnosis.
Compared with conventionalMRI, FFC-MRI requires
dedicated hardware to vary the magnetic field B0 rapidly
compared to the relaxation times. Implementation poses
strong constraints on magnet design, power supplies,
control electronics, pulse sequences, scan time and image
quality. These constraints require compromises and add
serious difficulties to the construction of FFC-MRI scan-
ners so that at present FFC-MRI system developments
are limited only to a small number of research groups
worldwide exploring different approaches ranging from
completely home-built human-scale systems at low field
to B0 insert coils for commercial MRI systems at clinical
fields of 1.5 T and 3 T.
The purpose of this article is to provide an overview of
the recent advances in the field of FFC-MRI and to review
different approaches as well as to present their advantages
and drawbacks. First we present an overview of FFC-
MRI hardware designs, their limitations and the error
correction strategies being employed. Then we present
the acquisition strategies currently developed to tackle
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image reconstruction problems that are specific to FFC-
MRI. Finally, we discuss the challenges and the potential
applications that can arise by exploiting the dispersive
properties of biological tissues and selectedMRI contrast
agents, transferring the underlying molecular dynamics
into new types of image contrast on biological tissues,
including living materials.
FFC-MRI technologies
Various systems exist that allow changing the magnetic
field during a pulse sequence in an FFC-MRI system.
Each technology presents its strengths and weaknesses.
An overview of the early developments and history of
FFC-MRI hardware systems can be found in references
[11,16] and a summary of the latest hardware systems
is presented in Table 1 and detailed below. Performing
FFC-MRI systems are expected: (i) to switch the main
magnetic field in a time shorter than the sample T1 at
these fields, (ii) to access a large range of magnetic field
strength in order to provide a large overview of the R1
NMRD profile, both at the high and low end of the Lar-
mor frequency spectrum and (iii) to be large enough to
accommodate relevant objects for imaging.
The practical implementation of these requirements
necessitate to make various compromises and several
designs exist that suit different purposes. FFC-MRI bears
resemblance with ultra-low field MRI [17], which is
not covered here, that similarly relies on electromag-
nets to produce a pre-polarising field but signal detection
is performed with SQUIDs (Superconducting Quantum
Interference Device) at the ultra-low field. Below is a
description of themagnet technologies currently used for
FFC-MRI.
Dual resistive and permanent whole-bodymagnets
This technology combines the stability of a permanent
magnet with the reactivity of a resistive one, both of
whole-body sizes. This approach has been developed in
Aberdeen,UK [18,21] and can reachmagnetic fields from
5 to 120 mT with an acquisition field of 59 mT. It consists
of a vertical-field ferrite magnet using a Halbach config-
uration and a vertical resistive insert magnet that adds to
or subtracts from the permanent field. The overall system
has a bore size of 52 cm, which is enough for whole-body
human scans.
A key element of the dual-magnet approach is that
signal acquisition takes place only in the field of the per-
manent magnet, with the insert magnet inactivated, and
the scanner exploits the short-term stability of the per-
manent magnet to avoid artefacts in the image, while
the resistive magnet varies the relaxation field over a
relatively large Larmor frequency range during the spin
preparation stage. One drawback of this design is that the
field inhomogeneities of the two magnets add up when
reaching very low B0 so that the lowest field attainable
is about 1 mT when scanning an object the size of a
head. Moreover, the use of ferrite magnets restricts the
imaging field to relatively weak B0, which limits polar-
isation (120 mT in the Aberdeen dual-magnet system)
and increases the scan time required to obtain exploitable
images. Additionally, the magnetic field generated by
permanent magnets is temperature-dependant (on the
order of 0.2% per degree for ferrite [18]), requiring either
to control the room air temperature or to monitor the
variations of the magnetic field.
Single resistivemagnet
FFC-MRI designs based on a single resistive magnet
present two main advantages: they can produce rela-
tively strong magnetic fields per weight compared with
a permanent magnet and the homogeneity of the magnet
scales with the current so that it is not the dominant lim-
itation when reaching very low magnetic fields. Current
developments focus on a completely resistivewhole-body
FFC-MRI device [19] in an effort to reach even lower B0
fields for relaxation on the one hand and to increase the
imaging field strength on the other hand. This scanner
has a bore of 50 cm, which is quite narrow but does per-
mit whole-body scans of slim people (see Figure 3(a)). It
is capable of reaching field strengths up to 0.2 T and down
to 100 μT but work is currently in progress to extend its
lower limit to 5 μT to extend the range of the NMRDpro-
file. The use of a purely resistive magnet makes it easier
to explore low magnetic fields because the magnet inho-
mogeneities scale down with the field strength so that
the limitations in the ultra-low field regime mainly come
from the Earth’s field (typically 40 μT depending on the
location) and from magnetic fluctuations from the envi-
ronment, such as moving elevators, nearby traffic, mains
electricity supply or ferromagnetic structures within the
building. The latter may generate local fields signifi-
cantly stronger than Earth’s as well as field gradients
(10–50 μT/m is not uncommon). However, FFC exper-
imentation imposes fast current variations in the magnet
so that its inductance must be kept to a minimum. Low
inductance makes it more difficult to drive the magnet
consistently and limits the field stability so that partic-
ularly stable and fast current amplifiers are required for
this scanner.
Superconductingmagnet with resistive insert coil
Alternatively, FFC-MRI can be implemented by inserting
a resistive B0 insert coil into an otherwise conventional
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clinical MRI system (see Figure 3(b)). The resistive B0
insert coil provides theB0 fieldmodulations necessary for
field-cycling experiments while images can be acquired
by theMRI system as usual. This combines the advantage
of a stable acquisition field, provided by the permanent or
superconducting primary magnet of a conventional MRI
system, with the fast-switching capability of a resistive
coil with low inductance. The offset coil can be mounted
on the patient table and positioned at the isocenter of
the main magnet. The insertion coil is designed for an
easy installation and removal, and provides a flexible
utilisation of the FFC technology, while maintaining the
basic operation mode of the MRI system. A schematic of
a typical on-site integration can be found in Figure 3(c).
Several research groups worldwide have realised this
approach, employing magnetic field strengths used in
current clinical routine such as 1.5 T and 3 T, in order to
implement amethod known as delta relaxation enhanced
magnetic resonance (dreMR) imaging, aimed at exploit-
ing the detection ofmolecules (including contrast agents)
with particular dispersion characteristics. Alford et al.
[22] at the University of Western Ontario were the first
Table 1. Overview of current FFC-MRI systems and their characteristics.
FFC-MRI Acquisition
system Type ﬁeld FFC range Bore size
Bödenler et al. [15] Insert coil 2.89 T 2.79–2.99 T Small animal
de Rochefort et al. [14] Insert coil 1.5 T 1–2 T Small animal
Harris et al. [12] Insert coil 1.5 T 1.28–1.72 T Small animal
Hoelscher et al. [13] Insert coil 1.5 T 1.41–1.59 T Small animal
Lurie et al. [18] Dual resistive and permanent 59 mT 5–120 mT Whole-body
Ross et al. [19] Resistive 0.2 T 0.1 mT–0.2 T Whole-body
Pine et al. [20] Insert coil 59 mT 3–115 mT Forearm
Figure 3. Integration of the FFC-MRI systems in their respective environments. (a) Current developments at the University of Aberdeen
focus on a completely resistive human-scale FFC-MRI device [19] reaching a ﬁeld strength up to 0.2 T. This scanner has a bore of 50 cm
allowing for whole-body scans of slim people. (b) Shows a resistive B0 insert coil within the bore of a superconducting magnet system
at a ﬁeld strength of 3 T [15]. Although this method uses clinical MRI systems for signal detection, the small bore sizes limit the imaging
volume topre-clinical small animal experiments. (c) Schematic of a typical on-site integrationof an insert coil for anotherwise commercial
MRI system.
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Table 2. Comparison of B0 insert coil speciﬁcations.
Imaging region Physical dimensions
dreMR coil B0 (mT) L (mH) R (m)
Field eﬃciency
(mT/A) Ø (mm)
Length
(mm)
Bore Ø
(mm)
Outer Ø
(mm)
Length
(mm)
Theoretical power
at max. ﬁeld
Hoelscher et al. [13] ±90 4.90 60 2.54 34 50 52 242 340 75 W
Harris et al. [12] ±220 1.46 95 0.87 25 50 80 320 420 6.1 kW
de Rochefort et al. [14] ±500 0.30 100 1.57 28 40 40 170 300 10 kW
Bödenler et al. [15] ±100 1.69 64 0.67 40 40 100 345 514 1.4 kW
to describe the use of an insert coil, capable of mod-
est field shifts of ±70 mT, within a clinical MRI system
with a nominal field strength of 1.5 T. Later on, this first
prototype insert coil design was improved by Harris et al.
[12] leading to B0 offset fields of ±0.22 T. Other systems
at 1.5 T were implemented by Hoelscher et al. [13] and
de Rochefort et al. [14], the latter reporting the currently
highestB0 of±0.5 T. Although themajority of available
hardware setups are based on 1.5 TMRI systems, recently,
Bödenler et al. [15] proposed an implementation centred
at a nominal B0 field strength of 2.89 T. Table 2 compares
hardware specifications like B0, inductance, resistance,
field efficiency, imaging region and physical dimensions
of B0 insert coils currently used for dreMR.
Despite the use of a clinical MRI system for signal
detection, the bore sizes of all these insert coils are small
(ranging from 40 to 100mm in diameter). The limitation
mostly comes from the inductive coupling between the
resistive insert and the superconducting magnet: large
currents are used in the resistive coil to generate large
magnetic fields that are switched quickly, so the large
variations of the insert stray field induce electric currents
in the conductive parts of the permanent magnet. These
currents may quench it during the B0 field ramps. One
way to mitigate this problem is to use an active shield to
minimise the interaction with the host system. Another
way is to reduce the size of the insert coil: the stray field
decreases with the cube of the diameter to distance ratio
so that smaller inserts produce a weaker stray field in
the scanner structure and allow maintaining fast ramps.
However, they offer a small imaging volume (ranging
from 25 to 40mm in diameter) that limits the use of such
systems to pre-clinical small animal experiments. Yet fea-
sibility studies byHarris et al. [23,24] have investigatedB0
insert coil designs suitable for human head and prostate
imaging, which is an important step for transferring the
dreMR method to human-scale applications.
Another important consideration is the power
deposited in such an insert coil as it scales with the square
of the required current and therefore field strength. Con-
sidering the designs presented in Table 2, it can be esti-
mated that the power dissipated by Joule effects at max-
imum fields ranges between 75 W to 10 kW. An adapted
cooling system is then required for heat extraction from
the resistive windings for each system. Limited cooling
capacity of the insert coil requires duty cycle adjustments
or/and the maximum field (current) must be reduced.
Therefore, a sufficient cooling capacity of the insert coil
has to be considered during the design process as a
change after construction is difficult. For example, the
insert coil from Hoelscher et al. is limited to a duty cycle
of 1:8 to allow for sufficient cooling. Harris et al. [12]
implemented an effective cooling system so that the oper-
ation (6 kW generated at maximum field) is only limited
by the duty-cycle of the power supply. They utilise a par-
allel water flow through each winding layer to increase
the water flow and therefore the heat extraction. The
cooling system involved in [14] (10 kWgenerated atmax-
imum field) has a primary closed-loop circuit with circu-
lating perfluorocarbon in contact with the insert coil and
a secondary circuit with circulating water. The insert coil
(1.4 kW atmaximumfield) in [15] employs a cooling sys-
tem with six internal multipath circuits filled with water
and the operation is only limited by the duty cycle of the
power supply.
In contrast to the horizontal-field scanner geome-
try used in the clinical MRI systems described above,
Pine et al. [20] presented a disk-shaped, vertical-field
insert coil for the use with a 59 mT permanent-magnet
vertical-field scanner. The combination of this geome-
try with a surface RF coil provides an improved flexi-
bility with respect to the imaging region of the patient
when compared to the reduction in accessible bore size
for a solenoidal insert coil geometry currently used in
horizontal-field MRI systems.
Technical comparisons
B0 field stability and homogeneity
Most MRI image acquisitions are performed in the k-
space and the phase of the NMR signal is essential for
the image reconstruction process. Errors in the phase
measurements in the order of half a degree or more lead
to visible ghosting artefacts that degrade the image (see
Figure 4). Tomitigate this problem, field inhomogeneities
are usually corrected by using spin echo sequences
but this approach has limited results for time-varying
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Figure 4. Small deviations of B0 induce shifts in the signal phase
that degrades the image producing ghosting artefacts e.g. (a)
phantom image obtained from a B0 insert coil [15] and (b) head
scan obtained from a resistive whole-body magnet [25].
fluctuations. The averageNMRphase from a simple spin-
echo experiment can be modelled as follows:
ϕ(2τ) = γ
[∫ τ
0
B0(t)dt −
∫ 2τ
τ
B0(t)dt
]
(1)
where τ is the delay between the excitation and refo-
cusing pulses, γ is the gyromagnetic ratio and ϕ(2τ) is
the phase of the NMR signal when the echo forms. One
can simplify the expression above by using a polynomial
expansion of the field B0:
ϕ(2τ) = γ
[∫ τ
0
∞∑
i=0
bitidt −
∫ 2τ
τ
∞∑
i=0
bitidt
]
(2)
where bi are the decomposition coefficients of the B0
series. This gives:
ϕ(2τ) = γ
∞∑
i=0
bi
i + 1τ
i+1[2 − 2i+1] (3)
The terms of this series only cancel out for constant fields
and dephasing increases with larger orders and with the
echo time. Hence phase errors can only be corrected
by better control of the magnetic field or by shorten-
ing the echo time, but the latter increases the acquisition
bandwidth and lowers the SNR.
Permanent or superconducting magnets have stabil-
ity time constant orders of magnitude larger than the
echo time so they are not affected by this problem and
any drift can be corrected by tracking the resonance fre-
quency every few minutes. Fast temporal fluctuations of
the magnetic field are mainly a problem when dealing
with resistive magnets, either in isolation or in an insert
system if the resistive coil is not disabled during image
acquisition. In such systems, the field fluctuations that
affect the phase of the NMR signal are due to imper-
fect control of the electric current by the magnet power
supply. Yet resistive magnets are natural low-pass filters
with a frequency f defined by their inductance L and
resistance R:
f = R/2πL (4)
It results that field stability is more easily achieved with
large inductance and low resistance (which requires some
compromises), however reducing the cut-off frequency of
the magnet also reduces its response time for the field
ramps and makes it more difficult to drive, requiring
power supplies able to provide large voltages. Particular
care is therefore necessary to design resistive magnets for
FFC-MRI to balance these needs. As an example, ramp
times are typically 1–10ms long whereas echo times can
reach 10–40ms, hence a possible trade-off could be to set
a cut-off frequency between 20 and 60Hz.
For the insert system with the highest field offset
reported above (500 mT obtained with 320 A, with and
a cut-off frequency of ∼50Hz [14]), the current fluctu-
ations remaining during signal acquisition are typically
producing NMR frequency fluctuations up to 200Hz.
To avoid such fluctuations during the acquisition phase,
which uses the stable main field of the superconduct-
ing magnet, an ad-hoc strategy is to switch to a highly
resistive state, which is equivalent to opening the coil cir-
cuit by disabling the amplifier [15]. Another approach
is to switch the amplifier load between the insert coil
and an inductance-matched dummy load using a fast
high-power solid state switch [12].
Whole-body resistive FFC-MRI scanners present less
problems and experimentation on the Aberdeen 0.2 T
system showed fluctuations lower than 2 ppm (8Hz pro-
ton Larmor frequency). It produces images with visible
artefacts but these can be corrected by post-processing
[25], where the background signal is minimised by find-
ing the optimum phase correction for each k-space line.
Theses resistive magnets also produce heat that leads
to field drift via thermal expansion, similar to what is
observed with permanent magnets. This effect can reach
0.1% of the full field so it is of little concern for insert
magnets but causes large field drifts in whole-body sys-
tems during the detection field. Correction techniques
can easily be applied by scaling B0 as the acquisition pro-
gresses, taking advantage of the long time constant asso-
ciated with such thermal effects (40min on the Aberdeen
0.2 T system). Yet this requires access to the data acquired
during the scan.
Permanent magnets also present problems with field
stability because of their temperature dependence. The
dual FFC-MRI magnet at Aberdeen is based on ferrite
and is thermally controlled but the resistive insert gen-
erates heat during field-cycled experiments. As a result,
B0 fluctuates over several kHz when acquiring field-
cycled T1 maps but the characteristic time of the drift is
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very long compared with an acquisition so that one can
make some corrections during the experiment, using one
acquisition set to correct for the next one. Note that in
this case the field correction cannot be done by adjusting
B0, but by adjusting the system frequency from the MRI
console.
Signal-to-noise ratio
Signal-to-noise ratio (SNR) is a crucial parameter for
MRI images: large SNR allows detecting with higher
accuracy and improved spatial resolution, which are
desirable for medical applications. SNR depends largely
on the acquisition field strength [26], which limits the
technology available for the detection of the NMR signal.
AtNMR frequencies typically higher than 1MHz (cor-
responding to 23 mT for 1H), inductive detection can
be used efficiently with mature technologies involving
preamplifiers, acquisition electronics and radiofrequency
coil designs. With such systems, the signal-to-noise ratio
is summarised as:
SNR = γNPKC
√
Tacq (5)
where γ is the gyromagnetic ratio, N is the number of
nuclei within the imaged volume, P is the polarisation
at equilibrium (which is proportional to the polarisation
field under the Curie law), K provides the sensitivity of
the RF detection coil (which is proportional to the acqui-
sition field), C relates to the contrast due to relaxation
and depends on the pulse sequence applied, and Tacq is
the total acquisition time. As can be seen, in the choice
of a strategy for FFC-MRI, the magnetic fields and their
timing during the three distinct phases of polarisation,
relaxation and acquisition interact in determining the
achievable SNR. Separating each phase, SNR increases
linearly with polarisation,motivating the use of high field
or pre-polarising approaches when lower field FFC-MRI
are used. Regarding the acquisition field, for biological
tissues maintained at body temperature, an optimised RF
detection setupwould be in the sample-noise dominating
regime, inwhichK is only dependent of the coil geometry
and not on the acquisition frequency. However, in prac-
tice this regime is not always reached, when other noise
sources dominate such as intrinsic RF coil noise, pream-
plifier noise and noise due to electromagnetic coupling
with the environment. The limitation of noise perfor-
mance depends on the acquisition field strength and RF
coil size, with higher fields being more susceptible to
patient noise while coil noise usually dominates at lower
fields. Regarding the relaxation field that provides the
image contrast, it is completely determined by the relax-
ation behaviour under the applied pulse sequence, with
a trend to have shorter T1 at lower fields, enabling to
sensitise faster to this parameter. Finally, if an SNR is
targeted for a given system, two basic imaging param-
eters can be adjusted to achieve it, the voxel size (to
increase the number of nuclei N), and the available time
the signal is actually acquired. In summary, an ideal sys-
tem would benefit from high-field pre-polarisation, opti-
mised acquisition field in the sample-noise dominating
regime, and from the most relevant relaxation field to
reveal field-dependant contrast.
However, in practice, experimental factors also impact
SNRdepending on the technology used. In particular, the
heat dissipation in the resistive coil in FFC-MRI requires
efficient cooling, and limitations of currently-available
power-supply amplifiers lead to limited duty-cycles of
the magnetic field. The most constrained systems in that
matter are the resistive FFC-MRImagnets such as the one
in Aberdeen which operates at a maximum of 50% duty
ratio to allow the current amplifiers to cool down when
operating at 0.2 T. Additionally, pre-polarisation at 0.2 T
can only last up to 2 s so that tissues with long T1 cannot
be completely polarised, which decreases SNR accord-
ingly. The cooling time is also lost in terms of acquisition
time and increases the scan duration, typically by a factor
1.2–2. Insert systems also have restrictions imposed by
their cooling systems but thesemainly impact themagnet
size because of the volume occupied by the cooling pipes.
RF coil setup
While a variety of commercial solutions exist for RF
coils used in conventional MRI systems, FFC-MRI scan-
ners present various non-standard features such that the
RF coil has to be home-built. Design considerations dif-
fer according to the frequency regime and the RF coils
designs vary between the insert and the whole-body
systems even if in both systems the ratio of the wave-
length to the cavity dimension is much larger than unity
and the birdcage or saddle coil geometries are well-suited
for the coil shape.
Insert magnet systems operating at 1.5 T or 3 T are
characterised by resonant frequencies on the order of
100MHz range and tight volume. An example of coil
for such systems is presented in Figure 5 [27]: its diam-
eter is set to fit tightly inside the insert bore of 40mm
diameter and the shield is very close to the coil dur-
ing insertion, which causes large detuning when inserted
inside the insert magnet. At high frequency the design
of the inductive loop also needs to take into account the
wavelength of the RF signal in the conductors. For MRI
systems operating at 1.5 T, the proton NMR frequency
is about 64MHz and the corresponding wavelength in
vacuum is 4.7 m. This number drops down to 2.8 m in
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Figure 5. Speciﬁc RF coil design (a) and small animal bed adapted to gaseous anaesthesia (b) ﬁtted to the tight available space due to
the small bore size of the B0 insert coil [27]. Exemplarily, an in vivomouse image (axial slice at the neck level) obtainedwith the dedicated
RF coil is shown in (c).
typical RG58 coaxial cables and is further reduced as
B0 increases. This requires particular care when plac-
ing lumped elements on large RF coils, such as used for
human scans, and numerical simulations are required to
validate the behaviour of the coil and avoid hot spots
that could generate RF burns. Baluns are also needed
at regular intervals along the transmission line to pre-
vent current conduction along the cable shield, which
could also result in burns and increases the signal noise,
though these problems are not significant for animal-size
systems.
Acquisition on the whole-body 0.2 T FFC-MRI scan-
ner also requires custom RF coil design to adapt to low-
frequencies, and this field strength is no longer used by
MRI manufacturers. Such coils typically include large
tuning capacitors, (typically hundreds or pF to several
nF), large matching capacitors to adapt the load to the
50 Ohms transmission line (usually hundreds of pF),
thick conductors to take advantage of the large skin
depth (100 μm to accommodate a skin depth of about
20 μm) and large windings or multiple turns to increase
the inductance. They also have some interesting bene-
fits such as negligible dephasing with conductor length,
since the wavelength at such frequencies is above 30
m, low power consumption from the RF power ampli-
fier, Q factors typically between 100 and 400 depending
on the geometry and low patient loading so that the Q
factor remains high when the coil is used (coil noise
regime). They also require very few baluns, if any, so the
risk of RF burns remains small. An important improve-
ment could come from the use of parallel imaging (PI)
techniques [28] in FFC-MRI. PI is a routine method to
accelerate image acquisition over a wide range of appli-
cations in conventional MRI, but this approach relies on
the use of coil arrays and such detectors require addi-
tional components such as pin diodes for active decou-
pling and low input impedance preamplifiers for passive
decoupling. The lack of readily available dedicated low-
impedance preamplifiers at frequencies below 20MHz
makes coil arrays difficult to build at low frequencies for
the moment. This is aggravated by the large inductors
needed at low magnetic fields, which cannot be minia-
turised into the currently existing high-field preampli-
fiers so that new designs must be created for applications
at the MHz regime. Additionally, filtering elements such
as present on the DC bias line of the PIN diodes are less
efficient at lowmagnetic fields so that a trade-off must be
found between the size and the signal loss of the coil array
control boards. Developments in this field are currently
ongoing in Aberdeen.
Eddy currents
FFC-MRI is prone to eddy currents resulting from the
fast variations of the resistive coil inducing currents in
all surrounding conductive materials. Their importance
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consequently depends on the scanner design. Insertmag-
nets tend to generate most eddy currents because of
the large amount of conductive materials incorporated
in the cryostats and support structures of supercon-
ductive magnets; eddy currents generated in liquid-He
temperature structures such as radiation shields may
be particularly problematic since the eddy current life-
time is prolonged due to high conductivity at low tem-
perature. Insert magnet coils may need to be actively
shielded in order to reduce the risk of quenching themain
magnet. Eddy currents do appear significantly in dual-
magnet FFC-MRI systems but a small delay before image
acquisition (∼1ms) is usually sufficient to avoid arte-
facts, and no eddy currents have been observed so far in
the Aberdeen team’s purely-resistive FFC-MRI magnet,
which can be explained by the absence of conductive sur-
faces around the magnet and the use of copper mesh for
the RF shield.
Most effects have been reported in the case of insert
coils into superconductive MRI systems used for dreMR
imaging [12,14,15,29]. Typically, to characterise them, a
B0 pulse of trapezoidal shape with defined ramps, flat
top time and amplitude is applied. The induced eddy cur-
rent field varies temporally and can be characterised by
a mono-exponential (or even multi-exponential) decay.
A comprehensive analysis of eddy current formation has
been given by Hoelscher et al. in [29]. The main problem
with induced eddy current fields is that they result in tem-
porally varying offset in the Larmor frequency. This fre-
quency offset gives rise to a shift of the field of view (FOV)
along frequency and slice encoding axis causing substan-
tial degradation of the dreMR image quality due to sub-
traction artefacts. A typical eddy current characterisation
can be found in Figure 6(a). The influence of the shifted
FOVon FFC-MRI images can be seen in Figure 6(b,c). To
illustrate this problem, we consider a systemwith amaxi-
mum gradient strength of 45mT/m acquiring over a slice
thickness of 1mm so that the maximum slice selection
transmit bandwidth would be around 1.9 kHz. In such
a situation the 380Hz (peak) frequency shift induced by
eddy currents as seen in Figure 6(c) dynamically shifts
the FOV in the slice direction by up to 200 μm, a dynamic
slice selection error of 20%. Similarly, such eddy currents
would produce a shift of 180 μm within the plane of the
image. This clearly indicates the need for a compensation
of such effects for such preclinical systems.
Two strategies are then usable to compensate for these
effects, the first one is to wait long enough to go below a
predefined shift level, the other is to compensate based
on an underlying calibrated linear model in prospec-
tive (through real-time RF modulation or compensation
coils) or retrospective (through signal demodulation)
ways, as the shifts are small enough to be restricted to
the bandwidth of the RF setup. One prospective way to
compensate eddy current effects, proposed by Hoelscher
et al. [29], is to modulate the system reference frequency
(based on the identified decay model) in such a way that
the offset between system reference frequency and Lar-
mor frequency is zero throughout the pulse sequence.
In principle, this compensation can be implemented into
any sequence type and does not require any additional
hardwaremodifications. Another approach implemented
by Harris et al. [12] is to apply an additional com-
pensation field with a dedicated low-power Helmholtz
coil counteracting the eddy current decay during image
acquisition.
Figure 6. (a) Measured (blue circles) frequency shift induced by eddy currents in the FFC-MRI system for 3 T (B0 = 100 mT, Tevol =
300 ms and ramp times of 1 ms) [15]. The red solid line represents a bi-exponential model ﬁt. This frequency oﬀset results in a shifted
image (c) with respect to the reference image (b) without applied B0. The shifted image in (c) corresponds to the frequency oﬀset in
the ﬁrst data point (ﬁlled circle) and clearly indicates the need to compensate for such eddy current eﬀects.
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Both approaches rely on an accurate eddy current
characterisation and may be compromised by phase
instabilities. It is important to note that the characteri-
sation parameters are specific to the parameters of the
B0 pulse such as amplitude, ramp times, flat top time
and repetition time. For example, a compensation based
on the parameters determined in Figure 6(a) is only valid
for aB0 pulse with an amplitude of 100 mT, duration of
300ms and ramp times of 1ms. The repetition time (TR)
has to be chosen to account for a sufficient eddy current
decay before applying the next field-shift. In this example,
a TR shorter than 900mswould lead to an incorrect com-
pensation as the eddy currents of the previous field-shift
add to the eddy current field of the next one. Further-
more, the characterisation parameters may be altered
slightly by a repositioning on the patient table between
experiments. In practice, however, these problems can
be overcome by performing a re-characterisation prior
the actual experiment to account for different timing and
field-shift parameters. Whereby, it is possible to account
for other effects like a slightly altered coupling between
the insert coil and the MRI system by a repositioning of
the coil on the patient table between experiments.
Pulse sequences
Magnetisation-prepared spin-echo pulse sequences have
been commonly used in FFC-MRI to determine R1 dis-
persionmaps (e.g. in [15,30,31]); this has been adopted as
it corresponds to the gold-standardway tomeasureR1. In
the most general case, it comprises three phases between
which the magnetic field B0 is switched: polarisation,
evolution and acquisition [11]. During the evolution
phase the spin system undergoes relaxation imposed by
the applied evolution field. Signal acquisition is always
carried out at the same detection field strength and can
either be the nominal B0 of a permanent or supercon-
ductingmagnet system, or at themaximumfield for resis-
tive magnets (coil noise dominance regime) to increase
SNR. A pre-polarisation of the magnetisation is not nec-
essarily required in the high SNR regime and therefore
the polarisation field is equal to the detection field. This
scheme has to be repeated in the usual manner for the
acquisition of the whole k-space.
One important limitation of FFC in the design of pulse
sequences comes from the detection technology. The use
of tuned transmit and receive coils imposes the use of the
corresponding field for detection and as a consequence
only the detection field allows modifying the spin sys-
tem by RF pulses, or detecting the NMR signal. This
forbids the use of speed-up strategies such as parallel
slice acquisitions, at least during the evolution field. FFC
measurements are also iterative: R1 maps are generated
for each evolution field by acquiring a series of images
with varying evolution times. As an example, a 128× 128
image with 12 sec repetition time, and 2 evolution fields
and 5 evolution times would provide a quantitative
R1/B0 map in 4 h and 16 min, which is definitely not
practical.
Depending on the application, qualitative R1/B0-
weighted images (e.g. dreMR image contrast) can be
acquired, as illustrated in Figure 7(b), in such case the
overall measurement time can be reduced by acquiring
only two images needed for image subtraction. In the
above example this would lead to a measurement time of
51min, which is achievable for in vivo scans but not prac-
tical for clinical use. It is therefore crucial in FFC-MRI
to speed up the measurement procedure under consid-
eration of particular hardware restrictions and without
significantly compromising the SNR.
FFC-MRI offers two ways to do so, either by speeding-
up k-space acquisition strategies or by exploiting the data
redundancy in the NMRD profile. For the latter, Broche
et al. [21] proposed a multi-field two-point method to
estimate R1 for different evolution fields, reducing the
number of images to one image per evolution field and
an additional reference image taken at the detection field.
This approach provides reasonably accurate R1 values
in less time and is valid for relatively linear regions in
the NMRD profile. To speed up k-space acquisition in
the context of FFC-MRI, several strategies have been fol-
lowed successfully, such as faster imaging modules like
RARE (Rapid Acquisition with Refocused Echoes) [32].
In contrast to conventional spin echo sequences, inRARE
imaging multiple lines of k-space are acquired within
one TR interval instead of only one. Echo train lengths
of up to 4 were used in studies by Ross et al. [30] and
Araya et al. [31] without image degradation. This speed
up by a factor of 4 reduces the acquisition time per
image in our example from approximately 25 min to a
reasonable 6 min. Furthermore, the use of steady-state
sequences like fast low-angle shot (FLASH) [33] or IR-
Look-Locker [34,35] may be considered in conjunction
with field-cycling. In the line of the adaptation of fastMRI
pulse sequence with R1 contrast, Chanet et al. [36] pro-
vided a theoretical derivation and analysis of the FLASH
steady-state signal equation modified for field-cycling.
Such sequences are usually used with short TRs, which,
on the one hand, may reduce the acquisition time signif-
icantly but on the other hand poses high demands on the
FFC hardware. In particular, TR could be limited by eddy
current effects, ramp times and/or duty-cycle of the field
shifts.
The choice of acquisition schemes is reduced in the
Aberdeen team’s resistive FFC-MRI scanner because of
the limited duty-cycle ratio of the scanner. As mentioned
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Figure 7. Comparison between FFC-MRI pulse sequences used for (a) quantitativeR1/B0 mapping and (b) qualitative R1 dispersion
imaging in the case of dreMR imaging. In (a) R1 mapping is performed at diﬀerent ﬁelds by acquiring a series of images with various Tevol
increasing the overall measurement time by the total number of needed Tevol and evolution ﬁelds. For example, a series of 10 images is
needed for 2 evolution ﬁelds (B0 ±B0) and 5 Tevol per ﬁeld. In comparison, for dreMR imaging in (b) only one Tevol is needed, which is
chosen in the order of T1 to maximise SNR, therefore the overall measurement time can be reduced to the acquisition time of 2 images
needed for image subtraction.
earlier, this scanner may overheat if driven continuously
and a 20–50% duty cycle must be observed to avoid
problems so that steady-state approaches are difficult to
develop. Additionally, the field temporal stability is rela-
tively poor and the signal phase fluctuates randomly with
a typical decorrelation time of 15ms, making CPMG or
other similar techniques inefficient. This also prevents
averaging the complex signal since the random phase
error tends to cancel the signal out.
Potential applications
Contrast-to-noise ratio
While SNR is important to characterise an MRI system,
Contrast-to-Noise Ratio (CNR) is what ultimately deter-
mines the usefulness of an image. We define CNR here
as how much the SNR varies with respect to an under-
lying physical parameter of interest. In MRI, the sources
of contrast mainly rely on T1 and T2 at fixed B0 field. In
FFC-MRI, the source of contrast up to now has mainly
been based on T1 dispersion. For instance, considering a
polynomial expansion of R1 around themagnetic field B0
as R1 = R10 +β*B0, where R10 is the relaxation rate at
the field B0, and β the slope of the dispersion profile, one
possible dreMR-related CNR could be:
CNR = SNR
B0
(6)
Indicating that dreMR contrast is maximised when
the slope of the signal is the largest. Considering an
inversion-recovery sequence, where the signal equation
is proportional to 1–2*exp(−R1*Tevol) with Tevol the
evolution time, in first approximation, the CNR, cor-
rected from thermal equilibriumwill vary as a function of
β*Tevol. Reciprocally, theCNRas a function ofβ is linked
to the productB0*Tevol, such that larger field offsets and
longer application times are more sensitive.
Besides T1, T2 dispersion may also be of interest.
However, it is technically difficult to maintain phase
coherence while switching the magnetic field. Initial
work has been done to access R2 dispersion profiles in
FFC-MRI systems [37], with the major target of endoge-
nous ferritin imaging [38] that, as a major component of
iron metabolism, may represent a biomarker of neurode-
generative diseases.
It is important to consider that T1 varies significantly
between differentmagnetic fields. This effect ismore pro-
nounced in tissues that disperse strongly, such as cartilage
or muscle, and less so in fatty tissues or brain. Other
effects may influence the contrast such as quadrupolar
relaxation, as explained later. Therefore, CNR using FFC-
MRI varies depending on the field strength that can be
accessed, and therefore on the technology employed, and
its evaluation and benefits for biomedical applications are
widely unexplored. Here we present some contrastmech-
anisms accessible by the FFC-MRI systems presented
here.
Quadrupole peaks due to 14N – 1H cross-relaxation
The presence of cross-linked proteins in tissues may
result in local increases in the R1 relaxation rate in the
dispersion curves of protons at particularmagnetic fields,
around 1H Larmor frequencies of 600 kHz, 2.2MHz and
2.8MHz, respectively. This quadrupole cross-relaxation
effect has been first reported in living biological tissues
by Kimmich et al. [39] and is now relatively well under-
stood as being due to a transfer ofmagnetisation between
water protons and the 14N nuclei, probably from amine
and/or amide groups of protein backbones, even though
the transfer mechanism from the protein proton to the
bulk water is still a topic of debate. Nevertheless, effi-
cient models exist that allow predicting this so-called
Quadrupole Enhanced Relaxation (QRE) for an arbitrary
quadrupole spin number [40].
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QRE from 14N is an interesting source of contrast
since it is naturally found in vivo and it directly informs
on the presence of immobilised proteins. Experiments
on cross-linked albumin [41] or the fibrin system [42]
showed that the amplitude of the peak is directly propor-
tional to the concentration of the protein responsible for
the relaxation enhancement, which makes this a quanti-
tative biomarker. However, experimentation on biolog-
ical tissues have so far only found the same pattern of
peaks, so this signal does not discriminate between dif-
ferent sources and does not inform on the nature of the
protein responsible for it. Another important aspect of
the 14N quadrupole peaks is that they appear at rela-
tively low magnetic fields so that they are not accessible
by high-field insert technologies such as those used for
dreMR.
Experiments with FFC-MRI scanner and FFC-NMR
relaxometer have shown interesting applications for the
14N quadrupole signals in muscle atrophy [43] and
osteoarthritis [10,44]. In both pathologies, the amplitude
of the peaks informs on the protein structures, which
relates to the pathology.
Dispersive contrast agents for FFC-MRI
The fact that some MRI contrast agents show a strong
dependence of R1 upon the magnetic field can be
exploited by FFC-MRI [45–47]. The idea is to acquire
one image (or even a relaxometric R1 map) for an evo-
lution field where the probe shows a high relaxivity, and
another one with an evolution field corresponding to a
low relaxivity. In this way one can obtain image con-
trast based on the slope dR1/dB0 of the contrast agent’s
NMRD profile. In the low field range, FFC-MRI mainly
relies on the large endogenous R1 dispersion of biological
tissues, which can show the aforementioned quadrupole
peaks due to 14N – 1H cross-relaxation, but can also ben-
efit from the use of exogenous contrast agents. O’Hogain
et al. [48] investigated the use of liposomes encapsulating
paramagnetic Mn[II] ions as a tailored FFC-MRI con-
trast agent for low field applications. This probe shows a
large difference in relaxivity values between 5 and 60 mT,
whereas the reference sample displays almost no change
in relaxivities over the same field range. In the high field
range (above 0.5 T), R1 dispersion of tissue becomes rel-
atively invariant as several NMRD studies have empha-
sised [49,50]. There is a relatively simple decrease of R1
with field above 0.5 T, with proposed descriptions involv-
ing amacromolecular-based power law and a logarithmic
term involving the restricted diffusive exploration of the
macromolecular interfaces [51]. Endogenous R1 disper-
sion properties can thus be characterised by a small num-
ber of parameters, including the slope of the dispersion
profile around the central B0 value, providing contrast
sensitive to the macromolecular content, although there
still are no in vivo studies exploiting this aspect with
FFC-MRI.
To date, FFC-MRI for typical clinical-system field
strengths (1.5 or 3.0 T) mainly relies on the use of con-
trast agents with a strong magnetic field dependency in
the corresponding field-cycling range. Alford et al. [52]
were the first to introduce the dreMRmethod for in vitro
differentiation between the bound and unbound state of
gadofosveset at 1.5 T. This probe exhibits a strong R1 dis-
persion upon activation by binding to large molecules
such as serum albumin but shows weak R1 dispersion
in the unbound state. Araya et al. [12] conducted in
vivo experiments with mice demonstrating an unam-
biguous localisation of gadofosveset activated by protein
binding. Hoelscher et al. [13] extended these results by
quantitative measurements of concentration using the
dispersive contrast agent Gadofluorine M. Furthermore,
it was shown by Bödenler et al. [15] that iron oxide mag-
netic nanoparticles (IOMNPs) are suitable for in-vitro
FFC-MRI studies up to 3 T. The corresponding NMRD
profiles, as illustrated in Figure 8(a), exhibit a sufficiently
highR1/B0 to perform dreMR imaging or relaxomet-
ric mapping in the field-cycling range of 2.89 T± 0.1 T
(Figure 8(b)).
All these results demonstrate the potential of FFC-
MRI in the field of contrast agents, to improve the
sensitivity and specificity of contrast agent detection
over a wide range of field strengths. Although approxi-
mately 40% of clinical MRI exams employ Gadolinium-
based CAs [53], the availability of clinical approved CAs
suitable for FFC-MRI is rather limited. The aforemen-
tioned gadofosveset was designed as blood pool agent for
contrast-enhancedMRangiography and is approved for a
clinical use [54]. This agent shows favourable dispersive
properties in the clinical field range between 1.5 T and
3 T, but the manufacturer discontinued the production
in 2017 [55]. Iron oxide nanoparticles also show disper-
sive properties in the clinical field range. For example,
ferumoxytol is approved by the United States Food and
Drug Administration (FDA) for treatment of iron defi-
ciency anaemia in adult patients and its off-label use as
MRI contrast agent has rapidly grown [56,57]. Over the
years, significant effort has gone into the development
of new MRI contrast agents but sophisticated toxicol-
ogy and pharmaceutical investigations are necessary to
take the step from preclinical development to approval
for clinical use.
One important means to determine the suitability of
contrast agents for FFC-MRI is the measurement of the
1H R1 NMRD profile by FFC-NMR relaxometry. For
paramagnetic systems the shape of the NMRD profile
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Figure 8. (a) 1H R1 NMRD proﬁles of cubic- and spherical-shaped IOMNPs with 1 mM concentration, compared to a reference NMRD
proﬁle of pure hexane. The IOMNPs show a signiﬁcantly high R1 dispersion in the high ﬁeld range to perform FFC-MRI studies up to 3
T. Based on the slope in the respective ﬁeld-cycling range, a R1/B0 image can be obtained by subtracting two R1 maps acquired at
diﬀerent ﬁelds. In particular, (b) shows aR1/B0 map obtained for an FFC range of 2.89 T± 0.1 T using samples containing a twofold
serial dilution series (top down, starting with 1 mM) of cubic (left) and spherical (right) IOMNPs. Samples with dispersive IOMNPs show
highR1/B0 in contrast to the non-dispersive reference sample (centre). [15]
is influenced by various parameters such as the water
exchange rate, coordination number, rotational correla-
tion time and electron spin relaxation [45]. As already
shown with the protein-binding gadofosveset, the most
promising for FFC-MRI are slowly tumbling systems
where the reorientational correlation time τR becomes
long. This leads to a relaxivity peak located between 20
and 80MHz followed by a steep downward slope which
can be exploited by a clinical FFC range. In future, it
may be possible to design contrast agents specific for
FFC-MRI by aiming for extremely high r1/B0 in the
activated state and almost nor1/B0 in the inactivated
state.
Potential frequency-selective contrast agents for
FFC-MRI
A promising alternative to the currently used contrast
agents for FFC-MRI is the design of frequency-selective
molecular probes based on Quadrupole Relaxation
Enhancement (QRE). The idea is to utilise QRE between
water protons and exogenous quadrupole nuclei, similar
to the aforementioned interaction between endogenous
1H and 14N in the amide groups of proteins at low field
strengths. QRE becomes effective if the 1H Larmor fre-
quency matches one of the frequencies with high tran-
sition probability of the quadrupole nuclei, a condition
which depends on the Quadrupole Coupling Constant
Qcc, the asymmetry parameter η and the Zeeman split-
ting [58]. Qcc and η are the main parameters describ-
ing the frequency positions of the nuclear quadrupole
spin transitions of a QRE active molecule. Consequently,
QRE based contrast agents show a frequency-selective
nature, similar to the quadrupole peaks due to 14N-1H
cross-relaxation.
For instance, several compounds containing high spin
quadrupole nuclei such as 209Bi show very characteris-
tic QRE patterns in the field range between 0.5 T and 3
T, as was recently shown by Kruk et al. [59] in NMRD
studies of solid powder samples. For the envisaged aim of
an exogenous QRE contrast agent, one would require, in
a next step, to show QRE in the liquid state by grafting
these core compounds onto nanoparticles and dissolve
them in an aqueous solution. The relaxation dynamics of
QRE in the liquid state can be simulated by the stochastic
Liouville approach [58,60,61]. As an example, a simulated
NMRD profile for a possible QRE contrast agent is dis-
played in Figure 9 for tris(2-methoxyphenyl)bismuthane.
SeveralQREpeaks emerging up to 3 T indicate the poten-
tial to exploit this frequency-selective nature with FFC-
MRI to enhance image contrast. Moreover, the overlay
with FFC ranges of currently available FFC-MRI sys-
tems clearly shows the benefit of a wide variety of cycling
ranges as it is completely unexplored at which field
strength such compounds lead to the best image contrast.
Another interesting consideration is that the Qcc is
sensitive to structural changes in the chemical surround-
ing of the quadrupole nuclei. It is possible to tune the
quadrupole transition frequency, and therefore the QRE
effect, by attaching different substituents to the core
compound. Recently, Gösweiner et al. [62] showed the
tuning possibilities of the resonance condition for var-
ious Bi-aryl compounds. Although current research is
focusing on 209Bi as core compound, it is also conceiv-
able to use other quadrupole nuclei to design QRE based
contrast agents specific for a FFC range of choice.
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Figure 9. 1H R1 NMRD proﬁle of a potential QRE based contrast agent simulated with the stochastic Liouville approach for a rotating,
coupled system 209Bi-1Hwith a rotational correlation time of 300 ns, inter-nucleus distance of 2 Å, Qcc of 715MHz and η = 0 (parameters
taken from [62]). The grey overlay illustrates achievable FFC ranges of diﬀerent FFC-MRI systems: (1) up to 0.2 T [19] (2) 1.5 T± 0.5 T [14]
and (3) 2.89 T± 0.1 T [15].
Figure 10. In vivo FFC-MRImeasurements in a kidney tumourmousemodel obtained from the preclinical insert system operating at 1.5
T ± 0.5 T [63]. (a) Standard spin-echo T1-weighted image (0.5 mm isotropic in-plane and 2.5 mm through-plane resolution, acquisition
time per image is ∼ 5min) of the abdomen of a mouse acquired at 1.5 T. (b) R1 map at 1.5 T corresponding to the white square in (a). (c)
Corresponding dispersion (−dR1/dB0) map calculated for three diﬀerent ﬁeld strengths of 1.34 T, 1.5 T and 1.66 T. The tumour displays
lower R1 and−dR1/dB0 than the medulla and kidney.
FFC-MRI on biological tissues
Thanks to the recent technological improvements of
FFC-MRI systems leading to exploitable image qual-
ity, initial in-vivo biomedical imaging applications are
emerging. Figures 10 and 11 display typical images
obtained with clinical and preclinical systems with
anatomical targets such as brain, musculoskeletal and
abdominal regions, and current pathological targets that
mostly focused on cancer. These examples illustrate
the excellent image quality that FFC-MRI can pro-
vide, and initial biomedical evaluation of the transla-
tion from FFC-NMR to FFC-MRI. In the future, it is
expected that the successful biological applications of
FFC-NMR [64] will be translated to FFC-MRI, lead-
ing to new imaging biomarkers of diseases that still
remain to be validated and compared to the already
rich contrast available on conventional fixed-field MRI
systems.
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Figure 11. Dataobtained fromwhole-bodyFFC-MRI scanners (from [43]). (a) 1 cm-thick sectionof thighsof ahealthy volunteer, obtained
at 59mT from thedual-magnet systempresented in [18]. Relaxometrywas performedusing FC-PRESSover a volumeof interest to provide
dispersion curves (b). (c) Spin echo image from a healthy volunteer’s head obtained at 0.2 T from the resistive magnet presented in [19]
(32 ms echo time, polarisation at 0.2 T for 0.3 s, 6 mm slice thickness, 2.3 mm in-plane resolution, 0.3 s recycle delay at Earth ﬁeld). The
T1 map at that ﬁeld is shown in (d); it clearly shows the diﬀerence between grey matter, white matter, and fatty tissues.
Conclusions
Fast Field-Cycling provides a wealth of information at
a molecular level and pioneer works on FFC-MRI show
promising results, but also additional technical complex-
ity. The compromises that have to be made to develop
FFC-MRI scanners have to balance field strength, B0
bandwidth, scanner size, field stability and scan time.
The technologies presented in this paper show several
approaches that allow exploring different regions of the
magnetic field strength and present different advantages
and drawbacks.
Extending the measurement of the dispersion curve
towards low magnetic fields is more easily performed
using a single electromagnet, at the cost of degraded field
stability. This may be mitigated by using detection meth-
ods at very low field and has the added benefit to provide
near-immunity against ferromagnetic elements, at the
cost of SNR and possible additional complexity. Fields
ranging between several mT and 0.5 T can be probed
using a combination of permanent and resistive mag-
nets. This prevents field fluctuations during readout but
limits the lowest field attainable. T1 dispersions at high
magnetic fields can be measured using a combination of
resistive insert coils and superconducting magnets. This
provides high SNR and resolution, at the cost of lower
usable volume and lower B0 bandwidth.
These various technical solutions allow covering a
wide range of the magnetic field spectrum and collab-
orative work is now possible to explore T1 dispersion
contrast mechanisms over 5 decades of B0, from 20 μT
to 3 T. This opens new research avenues for the discovery
of biomarkers as well as to better understand pathological
processes at themolecular level. In conclusion, FFC-MRI
is emerging as a powerful research tool readily available,
and future developments may enable exploring its large
potential for biomedical applications.
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